Neratinib price?

Question

Neratinib price?

Accepted Answer

Neratinib (brand name Nerlynx) – price snapshot (2024‑2026)

Region	Typical retail/average‑wholesale cost	Notes
United States	≈ $13,000–$14,000 per month (≈ $39–$42 k for a 3‑month supply)	Based on the manufacturer’s “Average Wholesale Price (AWP)” and the 2024 list price. Actual out‑of‑pocket costs will be lower for people with insurance, especially with a copay or coinsurance, and may be reduced by manufacturer‑sponsored discounts or patient‑assistance programs.
Canada	≈ CAD 12,000–13,000 per month	Comparable to U.S. pricing after currency conversion; provincial formularies and the Patented Medicine Price Review Board can affect the final amount paid.
Europe (EU‑27)	≈ €8,000–€10,000 per month	Prices vary by country; e.g., Germany ≈ €9,000, France ≈ €8,500. Many European countries negotiate lower prices with the manufacturer or use national pricing lists.
Australia	≈ AUD 10,000–11,000 per month	Price set by the Australian Therapeutic Goods Administration (TGA) and the Pharmaceutical Benefits Scheme (PBS) may apply a subsidy.
United Kingdom	≈ £7,500–£8,500 per month	The NHS (National Health Service) negotiates a discount, so the patient may pay nothing or a small NHS co‑payment depending on the local Clinical Commissioning Group (CCG).

Manufacturer list price – the amount that the drug manufacturer (Novartis) publishes for each 30‑day supply.
Insurance/Pharmacy Benefit Manager (PBM) contracts – most commercial insurers negotiate rebates that reduce the net cost to the patient.
Patient‑assistance programs – Novartis offers a program for uninsured or under‑insured patients. Eligibility is based on income, insurance status, and other criteria.
Government formularies – in countries with centralized pricing (e.g., Canada’s Patented Medicine Price Review Board, EU’s national price lists), the price can be significantly lower than the manufacturer list price.

Step	What to do	Who to contact
1	Ask your oncologist or pharmacist about the exact cost with your insurance (copay, coinsurance, deductible).	Your oncologist’s office / pharmacy
2	Check if you qualify for Novartis’s Patient Assistance Program.	Novartis Patient Assistance Program portal or your prescriber
3	Look into generic or biosimilar options. Currently, no generic Neratinib is approved, but new competitors may appear in the future.	Drug‑information databases (FDA, EMA)
4	Explore pharmacy discount cards (e.g., GoodRx, RxAssist) or manufacturer coupons if you’re paying out‑of‑pocket.	Online discount sites
5	Ask if the drug is available through clinical trial or expanded access programs, which sometimes provide it free of charge.	ClinicalTrials.gov or your treating physician

Average retail/wholesale price: ~$13–14 k/month in the U.S., comparable in other high‑income markets.
Actual out‑of‑pocket cost: Can be substantially lower thanks to insurance, rebates, or patient‑assistance programs.
If you need help: Talk to your oncology team, pharmacist, and look into the Novartis patient‑assistance program.

Feel free to let me know if you’d like more detailed information about a specific country’s pricing, how to apply for assistance, or anything else!

Ask Questions, Get Industry Insights … Instantly